Skip to main content
Signal8

PATTI JOSEPH M

SEC insider (Form 3/4/5 filer). CIK 0001283215. Director at Armata Pharmaceuticals, Inc. (ARMP). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 9, 2026. Located in LOS ANGELES, CA.

Companies PATTI JOSEPH M has filed insider reports for

  • Armata Pharmaceuticals, Inc. (ARMP): Director
PATTI JOSEPH M profile photo

PATTI JOSEPH M

CIK: 0001283215

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Armata Pharmaceuticals, Inc. logo
ARMP

Armata Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Armata Pharmaceuticals, Inc. logo
    ARMP

    Armata Pharmaceuticals, Inc.

    Mar 9, 2026
    Award

    Stock Options (Right to Buy)

    Direct
    25.6K shares-
  • Armata Pharmaceuticals, Inc. logo
    ARMP

    Armata Pharmaceuticals, Inc.

    Feb 5, 2025
    Award

    Stock Options (Right to Buy)

    Direct
    54.3K shares-

1-2 of 2